In a recent meta-analysis, Zeng L et al. analyzed available RCTs on GM-based therapy in SLE and concluded that, in general, probiotics have proven effective in reducing SLEDAI and total IgG levels and in increasing C3 complement fraction, with a good safety profile [105]. Here, C3 is linked to systemic lupus erythematosus.